Clinical Trial Update: Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update reporting efficacy and safety data for povorcitinib in adults with chronic spontaneous urticaria; results completed and posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angioedema
• Hives
• Idiopathic Urticaria
• Pruritus
• Spontaneous Urticaria
• Urticaria

Drugs mentioned

• Povorcitinib (povorcitinib)

Snippet

Sponsor: Incyte Corporation | Conditions: Urticaria, Chronic Spontaneous Urticaria | Phase 2 | Status: COMPLETED | Results posted: 2026-03-12